Biological Aspects of Schizophrenia

Abstract

Schizophrenia is a serious mental disorder that affects more than 2 million people in the United States. The pathophysiology of schizophrenia was originally linked to dysregulation of the dopaminergic pathways in the brain, but more recently has been linked to dysregulation of other neurotransmitter pathways as well particularly the serotonergic pathways. The positive symptoms of schizophrenia, which include hallucinations and delusions, are thought to be associated with disturbances in the mesolimbic dopaminergic system. Negative symptoms, including apathy and social withdrawal are believed to arise from alterations in the mesocortical system. The delicate interplay between the neurotransmitters dopamine and serotonin is now believed to be associated with the symptoms of schizophrenia. Structural brain abnormalities, including enlarged ventricles and cortical atrophy, may also play a role in schizophrenia.

Get full access to this article

View all access options for this article.

References

Azmitia, E. , & Whitaker-Azmitia, P. (1992). Awakening the sleeping giant: Anatomy and plasticity of the brain serotonergic system. Journal of Clinical Psycbiatry, 52, 1-14.

Bloom, F. , & Lazerson, A. (1988). Brain, mind, and behavior. 2nd ed. New York: W. H. Freeman.

Borison, R. L. , Diamond, B. I. , Pathiraja, A. , & Meibach, R. (1992). Clinical overview of risperidone. In H. Y. Meltzer (Ed.), Notel antipsychotic drugs (pp. 233-230). New York: Raven Press.

Carpenter, W. , & Buchanan, R. (1994). Medical progress: Schizophrenia. New England Journal of Medicine, 330, 681-689.

Cohen, J. , & Servan-Schreiber, D. (1993). A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophrenia Bulletin, 19, 85-104.

Kandel, E. R. (1991). Disorders of thought: Schizophrenia. In E. R. Kandel , J. H. Schwartz , & T. M. Jessell (Eds.), Principles of neural science (pp. 835-868). 3rd ed. East Norfolk, CT: Appleton & Lange.

Kaplan, H. I. , Sadock, B. J. , Eds. (1994). Synopsis of psychiatry (Vol. 7). Baltimore: Williams & Wilkins.

Meltzer, H. , ed. (1994). Novel antips ychotic drugs. New York: Raven Press.

Pickar, D. (1986). Neuroleptics, dopamine, and schizophrenia. Psychiatric Clinics of North America, 9, 35-45.

10.

Reynolds, G. P. (1989). Beyond the dopamine hypothesis: The neurochemical pathology of schizophrenia. British journal of Psychiatry, 155, 305-316.

11.

Sharif, Z. , Gewirtz, G. , & Iqbal, N. (1993). Brain imaging in schizophrenia: A review. Psychiatric Annals, 23. 123-134.